Viral Drug Sensitivity Testing Using Quantitative PCR Effect of Tyrosine Kinase Inhibitors on Polyomavirus BK Replication

Por Randhawa, Parmjeet S., Farasati, Noush A., Huang, Yuchen, Mapara, Markus Y., Shapiro, Ron
Publicado em 2010

Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity

Por Stenger, Elizabeth O., Turnquist, Hēth R., Mapara, Markus Y., Thomson, Angus W.
Publicado em 2012

Longitudinal bone marrow evaluations for myelodysplasia in myeloma patients before and after treatment with lenalidomide

Por Monaghan, Sara A., Dai, Lijun, Mapara, Markus Y., Normolle, Daniel P., Gollin, Susanne M., Lentzsch, Suzanne
Publicado em 2013

Absence of Stat1 in donor CD4(+) T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice

Por Ma, Huihui, Lu, Caisheng, Ziegler, Judith, Liu, Ailing, Sepulveda, Antonia, Okada, Hideho, Lentzsch, Suzanne, Mapara, Markus Y.
Publicado em 2011

Sequential Activation of Inflammatory Signaling Pathways During Graft-versus-Host Disease (GVHD): Early Role for STAT1 and STAT3

Por Ma, Hui-Hui, Ziegler, Judy, Li, Cuiling, Sepulveda, Antonia, Bedeir, Ahmed, Grandis, Jennifer, Lentzsch, Suzanne, Mapara, Markus Y.
Publicado em 2011

PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease

Por Qu, Zhaoxia, Fu, Jing, Ma, Huihui, Zhou, Jingjiao, Jin, Meihua, Mapara, Markus Y, Grusby, Michael J, Xiao, Gutian
Publicado em 2012

Filgrastim–Induced Crescentic Transformation of Recurrent IgG2λ GN

Por Batal, Ibrahim, Markowitz, Glen S., Wong, Waichi, Avasare, Rupali, Mapara, Markus Y., Appel, Gerald B., D'Agati, Vivette D.
Publicado no J Am Soc Nephrol (2016)

IL-12(hi) Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ—Dependent Apoptosis of Alloreactive CD4(+) T Cells In Vitro and Reduce Lethal Graft-Versus-Host Disease

Por Stenger, Elizabeth O., Rosborough, Brian R., Mathews, Lisa R., Ma, Huihui, Mapara, Markus Y., Thomson, Angus W., Turnquist, Hēth R.
Publicado em 2013

Osteopetrosis with Micro-lacunar Resorption due to Defective Integrin Organization

Por Blair, Harry C, Yaroslavskiy, Beatrice B, Robinson, Lisa J, Mapara, Markus Y, Pangrazio, Alessandra, Guo, Lida, Chen, Ka, Vezzoni, Paolo, Tolar, Jakub, Orchard, Paul J
Publicado em 2009

C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells

Por Pal, Rekha, Janz, Martin, Galson, Deborah L., Gries, Margarete, Li, Shirong, Jöhrens, Korinna, Anagnostopoulos, Ioannis, Dörken, Bernd, Mapara, Markus Y., Borghesi, Lisa, Kardava, Lela, Roodman, G. David, Milcarek, Christine, Lentzsch, Suzanne
Publicado em 2009

Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease

Por Fu, Jing, Li, Shirong, Feng, Rentian, Ma, Huihui, Sabeh, Farideh, Roodman, G. David, Wang, Ji, Robinson, Samuel, Guo, X. Edward, Lund, Thomas, Normolle, Daniel, Mapara, Markus Y., Weiss, Stephen J., Lentzsch, Suzanne
Publicado no J Clin Invest (2016)

Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 o...

Por Lentzsch, Suzanne, O'Sullivan, Amy, Kennedy, Ryan C., Abbas, Mohammad, Dai, Lijun, Pregja, Silvana Lalo, Burt, Steve, Boyiadzis, Michael, Roodman, G. David, Mapara, Markus Y., Agha, Mounzer, Waas, John, Shuai, Yongli, Normolle, Daniel, Zonder, Jeffrey A.
Publicado em 2012

Phase 1/2 trial of vorinostat plus tacrolimus and mycophenolate to prevent graft versus host disease following related donor reduced intensity conditioning allogeneic hematopoietic...

Por Choi, Sung Won, Braun, Thomas, Chang, Lawrence, Ferrara, James L.M., Pawarode, Attaphol, Magenau, John M., Hou, Guoqing, Beumer, Jan H., Levine, John E., Goldstein, Steve, Couriel, Daniel R., Stockerl-Goldstein, Keith, Krijanovski, Oleg I., Kitko, Carrie, Yanik, Gregory A., Lehmann, Michael H., Tawara, Isao, Sun, Yaping, Paczesny, Sophie, Mapara, Markus Y., Dinarello, Charles A., DiPersio, John F., Reddy, Pavan
Publicado em 2013

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an...

Por Armand, Philippe, Nagler, Arnon, Weller, Edie A., Devine, Steven M., Avigan, David E., Chen, Yi-Bin, Kaminski, Mark S., Holland, H. Kent, Winter, Jane N., Mason, James R., Fay, Joseph W., Rizzieri, David A., Hosing, Chitra M., Ball, Edward D., Uberti, Joseph P., Lazarus, Hillard M., Mapara, Markus Y., Gregory, Stephanie A., Timmerman, John M., Andorsky, David, Or, Reuven, Waller, Edmund K., Rotem-Yehudar, Rinat, Gordon, Leo I.
Publicado no J Clin Oncol (2013)